pharmaceutical benefits scheme

Submission

Mental Health Australia’s submission to the Review of the Pharmaceutical Benefits Advisory Committee’s guidelines.

Submission

The MHCA focus for this submission is on Cabinet’s proposal to become the decision-making body for approving all Pharmaceutical Benefits Scheme listings. The MHCA makes a number of recommendations to ensure that a high level of equity, accountability and transparency is maintained in Pharmaceutical Benefits Advisory Committee processes.

Submission

The MHCA urges this Inquiry to consider the health needs and circumstances of mental health consumers and carers to ensure safety and equity of access to medicines under the Pharmaceutical Benefits Scheme.

Subscribe to RSS - pharmaceutical benefits scheme